C-MER Medical (03309) Announces 150,000 Share Repurchase and Adjusts Treasury Shares to 20.29 Million

Bulletin Express

Feb 16

C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback represented approximately 0.0124% of the company’s issued shares (excluding treasury shares) and involved a total cost of HKD 223,500. Following the transaction, the number of treasury shares increased from 20.14 million to 20.29 million, while the total issued shares remained at 1.23 billion, with 1.21 billion shares excluding treasury shares.

According to the announcement, the repurchase was conducted under a mandate passed on 19 May 2025, which authorizes a total repurchase of up to 125.56 million shares. As of the transaction date, the repurchased shares constituted 0.0119% of the total issued shares (excluding treasury shares) under that mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1180177991"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180177991\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180177991?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-16 13:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180177991","market":"hk","top_or_hot":-1,"title":"C-MER Medical (03309) Announces 150,000 Share Repurchase and Adjusts Treasury Shares to 20.29 Million","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback represented approximately 0.0124% of the company’s issued shares (excluding treasury shares) and involved a total cost of HKD 223,500. Following the transaction, the number of treasury shares increased from 20.14 million to 20.29 million, while the total issued shares remained at 1.23 billion, with 1.21 billion shares excluding treasury shares.</p>\n<p>According to the announcement, the repurchase was conducted under a mandate passed on 19 May 2025, which authorizes a total repurchase of up to 125.56 million shares. As of the transaction date, the repurchased shares constituted 0.0119% of the total issued shares (excluding treasury shares) under that mandate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical (03309) Announces 150,000 Share Repurchase and Adjusts Treasury Shares to 20.29 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical (03309) Announces 150,000 Share Repurchase and Adjusts Treasury Shares to 20.29 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-16 13:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback represented approximately 0.0124% of the company’s issued shares (excluding treasury shares) and involved a total cost of HKD 223,500. Following the transaction, the number of treasury shares increased from 20.14 million to 20.29 million, while the total issued shares remained at 1.23 billion, with 1.21 billion shares excluding treasury shares.</p>\n<p>According to the announcement, the repurchase was conducted under a mandate passed on 19 May 2025, which authorizes a total repurchase of up to 125.56 million shares. As of the transaction date, the repurchased shares constituted 0.0119% of the total issued shares (excluding treasury shares) under that mandate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1180177991","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180177991","pubTimestamp":1771219463,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗(03309)公告回购15万股并调整库存股至2029万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (stock code: 03309) disclosed that on 16 February 2026, it repurchased 150,000 ordinary shares on the Hong Kong Stock Exchange at HKD 1.49 per share. The buyback represented approximately 0.0124% of the company’s issued shares (excluding treasury shares) and involved a total cost of HKD 223,500. Following the transaction, the number of treasury shares increased from 20.14 million to 20.29 million, while the total issued shares remained at 1.23 billion, with 1.21 billion shares excluding treasury shares.\nAccording to the announcement, the repurchase was conducted under a mandate passed on 19 May 2025, which authorizes a total repurchase of up to 125.56 million shares. As of the transaction date, the repurchased shares constituted 0.0119% of the total issued shares (excluding treasury shares) under that mandate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}